🎾 Corticosteroid Injection Outcome Simulator

Chronic Lateral Epicondylitis

Tennis elbow begins as tendon overuse injury, not inflammation.

• 1–3%: Adult prevalence (of the general population per year)
• 35–54: Peak age range (dominant-arm overuse most common)
• Angiofibroblastic: Tissue pathology (disorganized collagen, not true inflammation)
• 6–24 mo: Typical duration (often resolves without any treatment)

Degenerated tendon origin

The extensor carpi radialis brevis tendon degenerates at its origin.

Despite the name, true inflammation is often minimal or absent.

Collagen disorganization

Collagen fibers lose their normal parallel alignment over time.

Pain signaling

Nerve ingrowth into damaged tissue drives persistent local pain.

Corticosteroid Injection At The Tendon Origin

A corticosteroid is injected near the lateral epicondyle.

• Triamcinolone: Common agent (or methylprednisolone, injected locally)
• <10 min: Procedure time (brief in-office needle injection)
• Anti-inflammatory: Mechanism (suppresses local pain signaling molecules)
• None: Structural effect (does not repair degenerated collagen)

Local anti-inflammatory action

Corticosteroid suppresses local inflammatory and pain-signaling molecules.

No regenerative effect

The injection does not rebuild degenerated collagen fibers.

Repeat steroid use may even weaken the surrounding tendon tissue.

Placement matters

Precise placement at the tendon origin maximizes short-term effect.

Rapid Pain Reduction

Pain drops quickly within days to a few weeks.

• 2–7 days: Relief onset (faster than natural recovery alone)
• 70–90%: Short-term success (pain reduction reported at 4–6 weeks)
• Improves: Grip strength (temporarily, alongside early pain relief)
• Modest edge: Vs. placebo (saline injection in early weeks)

Fast but temporary

Relief reflects symptom suppression, not underlying tissue healing.

Early gains often mask a worse long-term recovery trajectory.

Functional improvement

Patients often resume gripping and lifting activities sooner.

The trade-off begins

Early success can delay more durable treatment approaches.

Relief Plateaus Or Partially Returns

Benefit fades as the corticosteroid effect wears off.

• 6–12 wks: Effect window (typical corticosteroid duration of action)
• Common: Pain rebound (symptoms partially return by week 12)
• Reverses: Vs. physiotherapy (exercise overtakes injection by 6 months)
• Diminishing: Repeat injections (returns with each subsequent dose)

Symptom rebound

Pain gradually creeps back as the drug effect clears.

Comparative trials

Physiotherapy overtakes corticosteroids in outcomes by three months.

Landmark trials show worse 1-year outcomes after injection than waiting.

Tissue still unchanged

The underlying degenerated collagen remains exactly as before.

Recurrence And Unresolved Degeneration

Corticosteroids never address the underlying tendon degeneration.

• Up to 72%: 1-year recurrence (symptoms return after initial relief)
• Higher: Repeat injection risk (tendon rupture risk with reuse)
• Eccentric exercise: Better long-term option (or PRP for durable outcomes)
• 0%: Structural repair (achieved from corticosteroid alone)

Degeneration persists

Disorganized collagen never reorganizes from corticosteroid exposure.

Repeated injections raise rupture risk without fixing the tendon.

Why relief fades

Suppressing pain signals cannot substitute for tissue repair.

Durable alternatives

Eccentric loading and PRP better address the root pathology.